+1 347 708 0418
The Pet Biopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pet Biopharmaceuticals size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Pet Biopharmaceuticals market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pet Biopharmaceuticals market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antiparasitic
Biological Products
Antibacterial
Others
Market segment by Application, can be divided into
Prevention
Treatment
Market segment by players, this report covers
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pet Biopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pet Biopharmaceuticals, with revenue, gross margin and global market share of Pet Biopharmaceuticals from 2019 to 2021.
Chapter 3, the Pet Biopharmaceuticals competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Pet Biopharmaceuticals market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Pet Biopharmaceuticals research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Pet Biopharmaceuticals
1.2 Classification of Pet Biopharmaceuticals by Type
1.2.1 Overview: Global Pet Biopharmaceuticals Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Pet Biopharmaceuticals Revenue Market Share by Type in 2020
1.2.3 Antiparasitic
1.2.4 Biological Products
1.2.5 Antibacterial
1.2.6 Others
1.3 Global Pet Biopharmaceuticals Market by Application
1.3.1 Overview: Global Pet Biopharmaceuticals Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Prevention
1.3.3 Treatment
1.4 Global Pet Biopharmaceuticals Market Size & Forecast
1.5 Global Pet Biopharmaceuticals Market Size and Forecast by Region
1.5.1 Global Pet Biopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Pet Biopharmaceuticals Market Size by Region, (2016-2021)
1.5.3 North America Pet Biopharmaceuticals Market Size and Prospect (2016-2026)
1.5.4 Europe Pet Biopharmaceuticals Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Pet Biopharmaceuticals Market Size and Prospect (2016-2026)
1.5.6 South America Pet Biopharmaceuticals Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Pet Biopharmaceuticals Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pet Biopharmaceuticals Market Drivers
1.6.2 Pet Biopharmaceuticals Market Restraints
1.6.3 Pet Biopharmaceuticals Trends Analysis
2 Company Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Pet Biopharmaceuticals Product and Solutions
2.1.4 Zoetis Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Zoetis Recent Developments and Future Plans
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Product and Solutions
2.2.4 Boehringer Ingelheim Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Boehringer Ingelheim Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Pet Biopharmaceuticals Product and Solutions
2.3.4 Merck Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Recent Developments and Future Plans
2.4 Elanco
2.4.1 Elanco Details
2.4.2 Elanco Major Business
2.4.3 Elanco Pet Biopharmaceuticals Product and Solutions
2.4.4 Elanco Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Elanco Recent Developments and Future Plans
2.5 Virbac
2.5.1 Virbac Details
2.5.2 Virbac Major Business
2.5.3 Virbac Pet Biopharmaceuticals Product and Solutions
2.5.4 Virbac Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Virbac Recent Developments and Future Plans
2.6 Dechra Veterinary Products
2.6.1 Dechra Veterinary Products Details
2.6.2 Dechra Veterinary Products Major Business
2.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Product and Solutions
2.6.4 Dechra Veterinary Products Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Dechra Veterinary Products Recent Developments and Future Plans
2.7 Ceva
2.7.1 Ceva Details
2.7.2 Ceva Major Business
2.7.3 Ceva Pet Biopharmaceuticals Product and Solutions
2.7.4 Ceva Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Ceva Recent Developments and Future Plans
2.8 Vetoquinol
2.8.1 Vetoquinol Details
2.8.2 Vetoquinol Major Business
2.8.3 Vetoquinol Pet Biopharmaceuticals Product and Solutions
2.8.4 Vetoquinol Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Vetoquinol Recent Developments and Future Plans
2.9 Ouro Fino Saude
2.9.1 Ouro Fino Saude Details
2.9.2 Ouro Fino Saude Major Business
2.9.3 Ouro Fino Saude Pet Biopharmaceuticals Product and Solutions
2.9.4 Ouro Fino Saude Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Ouro Fino Saude Recent Developments and Future Plans
2.10 Norbrook
2.10.1 Norbrook Details
2.10.2 Norbrook Major Business
2.10.3 Norbrook Pet Biopharmaceuticals Product and Solutions
2.10.4 Norbrook Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Norbrook Recent Developments and Future Plans
2.11 Jindun
2.11.1 Jindun Details
2.11.2 Jindun Major Business
2.11.3 Jindun Pet Biopharmaceuticals Product and Solutions
2.11.4 Jindun Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Jindun Recent Developments and Future Plans
2.12 Chopperlvya Animal Health
2.12.1 Chopperlvya Animal Health Details
2.12.2 Chopperlvya Animal Health Major Business
2.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Product and Solutions
2.12.4 Chopperlvya Animal Health Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Chopperlvya Animal Health Recent Developments and Future Plans
2.13 CAHIC
2.13.1 CAHIC Details
2.13.2 CAHIC Major Business
2.13.3 CAHIC Pet Biopharmaceuticals Product and Solutions
2.13.4 CAHIC Pet Biopharmaceuticals Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 CAHIC Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pet Biopharmaceuticals Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Pet Biopharmaceuticals Players Market Share
3.2.2 Top 10 Pet Biopharmaceuticals Players Market Share
3.2.3 Market Competition Trend
3.3 Pet Biopharmaceuticals Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pet Biopharmaceuticals Revenue and Market Share by Type (2016-2021)
4.2 Global Pet Biopharmaceuticals Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Pet Biopharmaceuticals Revenue Market Share by Application (2016-2021)
5.2 Pet Biopharmaceuticals Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Pet Biopharmaceuticals Revenue by Type (2016-2026)
6.2 North America Pet Biopharmaceuticals Revenue by Application (2016-2026)
6.3 North America Pet Biopharmaceuticals Market Size by Country
6.3.1 North America Pet Biopharmaceuticals Revenue by Country (2016-2026)
6.3.2 United States Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
6.3.3 Canada Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
6.3.4 Mexico Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Pet Biopharmaceuticals Revenue by Type (2016-2026)
7.2 Europe Pet Biopharmaceuticals Revenue by Application (2016-2026)
7.3 Europe Pet Biopharmaceuticals Market Size by Country
7.3.1 Europe Pet Biopharmaceuticals Revenue by Country (2016-2026)
7.3.2 Germany Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
7.3.3 France Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
7.3.5 Russia Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
7.3.6 Italy Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pet Biopharmaceuticals Revenue by Type (2016-2026)
8.2 Asia-Pacific Pet Biopharmaceuticals Revenue by Application (2016-2026)
8.3 Asia-Pacific Pet Biopharmaceuticals Market Size by Region
8.3.1 Asia-Pacific Pet Biopharmaceuticals Revenue by Region (2016-2026)
8.3.2 China Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
8.3.3 Japan Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
8.3.4 South Korea Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
8.3.5 India Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
8.3.7 Australia Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Pet Biopharmaceuticals Revenue by Type (2016-2026)
9.2 South America Pet Biopharmaceuticals Revenue by Application (2016-2026)
9.3 South America Pet Biopharmaceuticals Market Size by Country
9.3.1 South America Pet Biopharmaceuticals Revenue by Country (2016-2026)
9.3.2 Brazil Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
9.3.3 Argentina Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pet Biopharmaceuticals Revenue by Type (2016-2026)
10.2 Middle East & Africa Pet Biopharmaceuticals Revenue by Application (2016-2026)
10.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Country
10.3.1 Middle East & Africa Pet Biopharmaceuticals Revenue by Country (2016-2026)
10.3.2 Turkey Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
10.3.4 UAE Pet Biopharmaceuticals Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Pet Biopharmaceuticals Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Pet Biopharmaceuticals Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Pet Biopharmaceuticals Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Pet Biopharmaceuticals Revenue (USD Million) by Region (2016-2021)
Table 5. Global Pet Biopharmaceuticals Revenue Market Share by Region (2021-2026)
Table 6. Zoetis Corporate Information, Head Office, and Major Competitors
Table 7. Zoetis Major Business
Table 8. Zoetis Pet Biopharmaceuticals Product and Solutions
Table 9. Zoetis Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 11. Boehringer Ingelheim Major Business
Table 12. Boehringer Ingelheim Pet Biopharmaceuticals Product and Solutions
Table 13. Boehringer Ingelheim Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck Pet Biopharmaceuticals Product and Solutions
Table 17. Merck Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Elanco Corporate Information, Head Office, and Major Competitors
Table 19. Elanco Major Business
Table 20. Elanco Pet Biopharmaceuticals Product and Solutions
Table 21. Elanco Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Virbac Corporate Information, Head Office, and Major Competitors
Table 23. Virbac Major Business
Table 24. Virbac Pet Biopharmaceuticals Product and Solutions
Table 25. Virbac Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Dechra Veterinary Products Corporate Information, Head Office, and Major Competitors
Table 27. Dechra Veterinary Products Major Business
Table 28. Dechra Veterinary Products Pet Biopharmaceuticals Product and Solutions
Table 29. Dechra Veterinary Products Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Ceva Corporate Information, Head Office, and Major Competitors
Table 31. Ceva Major Business
Table 32. Ceva Pet Biopharmaceuticals Product and Solutions
Table 33. Ceva Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Vetoquinol Corporate Information, Head Office, and Major Competitors
Table 35. Vetoquinol Major Business
Table 36. Vetoquinol Pet Biopharmaceuticals Product and Solutions
Table 37. Vetoquinol Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Ouro Fino Saude Corporate Information, Head Office, and Major Competitors
Table 39. Ouro Fino Saude Major Business
Table 40. Ouro Fino Saude Pet Biopharmaceuticals Product and Solutions
Table 41. Ouro Fino Saude Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Norbrook Corporate Information, Head Office, and Major Competitors
Table 43. Norbrook Major Business
Table 44. Norbrook Pet Biopharmaceuticals Product and Solutions
Table 45. Norbrook Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Jindun Corporate Information, Head Office, and Major Competitors
Table 47. Jindun Major Business
Table 48. Jindun Pet Biopharmaceuticals Product and Solutions
Table 49. Jindun Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Chopperlvya Animal Health Corporate Information, Head Office, and Major Competitors
Table 51. Chopperlvya Animal Health Major Business
Table 52. Chopperlvya Animal Health Pet Biopharmaceuticals Product and Solutions
Table 53. Chopperlvya Animal Health Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. CAHIC Corporate Information, Head Office, and Major Competitors
Table 55. CAHIC Major Business
Table 56. CAHIC Pet Biopharmaceuticals Product and Solutions
Table 57. CAHIC Pet Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Pet Biopharmaceuticals Revenue (USD Million) by Players (2019-2021)
Table 59. Global Pet Biopharmaceuticals Revenue Share by Players (2019-2021)
Table 60. Breakdown of Pet Biopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Pet Biopharmaceuticals Players Head Office, Products and Services Provided
Table 62. Pet Biopharmaceuticals Mergers & Acquisitions in the Past Five Years
Table 63. Pet Biopharmaceuticals New Entrants and Expansion Plans
Table 64. Global Pet Biopharmaceuticals Revenue (USD Million) by Type (2016-2021)
Table 65. Global Pet Biopharmaceuticals Revenue Share by Type (2016-2021)
Table 66. Global Pet Biopharmaceuticals Revenue Forecast by Type (2021-2026)
Table 67. Global Pet Biopharmaceuticals Revenue by Application (2016-2021)
Table 68. Global Pet Biopharmaceuticals Revenue Forecast by Application (2021-2026)
Table 69. North America Pet Biopharmaceuticals Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Pet Biopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Pet Biopharmaceuticals Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Pet Biopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Pet Biopharmaceuticals Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Pet Biopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Pet Biopharmaceuticals Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Pet Biopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Pet Biopharmaceuticals Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Pet Biopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Pet Biopharmaceuticals Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Pet Biopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Pet Biopharmaceuticals Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Pet Biopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Pet Biopharmaceuticals Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Pet Biopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Pet Biopharmaceuticals Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Pet Biopharmaceuticals Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Pet Biopharmaceuticals Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Pet Biopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Pet Biopharmaceuticals Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Pet Biopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Pet Biopharmaceuticals Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Pet Biopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Pet Biopharmaceuticals Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Pet Biopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Pet Biopharmaceuticals Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Pet Biopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Pet Biopharmaceuticals Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Pet Biopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Pet Biopharmaceuticals Picture
Figure 2. Global Pet Biopharmaceuticals Revenue Market Share by Type in 2020
Figure 3. Antiparasitic
Figure 4. Biological Products
Figure 5. Antibacterial
Figure 6. Others
Figure 7. Pet Biopharmaceuticals Revenue Market Share by Application in 2020
Figure 8. Prevention Picture
Figure 9. Treatment Picture
Figure 10. Global Pet Biopharmaceuticals Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Pet Biopharmaceuticals Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Pet Biopharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 13. Global Pet Biopharmaceuticals Revenue Market Share by Region in 2020
Figure 14. North America Pet Biopharmaceuticals Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Pet Biopharmaceuticals Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Pet Biopharmaceuticals Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Pet Biopharmaceuticals Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Pet Biopharmaceuticals Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Pet Biopharmaceuticals Market Drivers
Figure 20. Pet Biopharmaceuticals Market Restraints
Figure 21. Pet Biopharmaceuticals Market Trends
Figure 22. Zoetis Recent Developments and Future Plans
Figure 23. Boehringer Ingelheim Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Elanco Recent Developments and Future Plans
Figure 26. Virbac Recent Developments and Future Plans
Figure 27. Dechra Veterinary Products Recent Developments and Future Plans
Figure 28. Ceva Recent Developments and Future Plans
Figure 29. Vetoquinol Recent Developments and Future Plans
Figure 30. Ouro Fino Saude Recent Developments and Future Plans
Figure 31. Norbrook Recent Developments and Future Plans
Figure 32. Jindun Recent Developments and Future Plans
Figure 33. Chopperlvya Animal Health Recent Developments and Future Plans
Figure 34. CAHIC Recent Developments and Future Plans
Figure 35. Global Pet Biopharmaceuticals Revenue Share by Players in 2020
Figure 36. Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Pet Biopharmaceuticals Revenue Market Share in 2020
Figure 38. Global Top 10 Players Pet Biopharmaceuticals Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Pet Biopharmaceuticals Revenue Share by Type in 2020
Figure 41. Global Pet Biopharmaceuticals Market Share Forecast by Type (2021-2026)
Figure 42. Global Pet Biopharmaceuticals Revenue Share by Application in 2020
Figure 43. Global Pet Biopharmaceuticals Market Share Forecast by Application (2021-2026)
Figure 44. North America Pet Biopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 45. North America Pet Biopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 46. North America Pet Biopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 47. United States Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Pet Biopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 51. Europe Pet Biopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 52. Europe Pet Biopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 53. Germany Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Pet Biopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Pet Biopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Pet Biopharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 61. China Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Pet Biopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 68. South America Pet Biopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 69. South America Pet Biopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Pet Biopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Pet Biopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Pet Biopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Pet Biopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Buy
